The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© Thomson Reuters 2022.Shionogi says Japanese gov't will buy 1 million more doses of COVID pill
TOKYO©2025 GPlusMedia Inc.
The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© Thomson Reuters 2022.
17 Comments
theResident
Good strategy going into the middle of the Winter Months. Keep as many beds free for those that will inevitably need them.
Sanjinosebleed
Waste of money. I'd be most re concerned about the side effects from the drug than the virus!
Raw Beer
That money would be better spent on cheap and effective repurposed drugs.
theResident
@Raw Beer; No - They don't work.
Mat
I suspect this purchase will be quite profitable.
wolfshine
Wonderful. Happy to see any company bite into the market share of Pfizer's empire, even if it's just a little.
kyushubill
Ah the same company busted selling placebos instead of actual meds to India, Brazil, and Mexico a few years ago.
Kumagaijin
Hopefully the money that is spent on these vaccines goes into gain-of-function research so we can be prepared for the next pandemic.
Fuzzy
Who picked that photo for this article? And what exactly are they trying to communicate with it?
Andy
Eventually someone might even come up with a pill or a vaccine that actually prevents infection and transmission.
Mark
No Thank You, I'll stick with Pfizer at least I know it works.
Seven
Let's dig a little deeper:
https://www.shionogi.com/global/en/news/2022/11/e20221122.html
https://biopharma.media/xocova-powerful-new-japanese-drug-for-coronavirus-treatment-3494/
I will refrain from sharing my opinion. Draw your own conclusion.
Hervé L'Eisa
Rather than ingesting these experimental products, it would be better to strengthen your immune system.
virusrex
That have been demonstrated above any rational doubt to be worthless against covid? that means money used on them would be completely wasted, or worse, it would make the patients be at a higher risks because of the well known toxicity they have.